Stage 01
Decide
Blueprint Care
Read the whole tumour and rank the best treatment plan.
Blueprint CareIf this is where you are
Newly diagnosedReports arriving, no plan yetAlready tested elsewhereYou have results you cannot readOn treatment nowYou want to know it is workingOr
Finished treatmentWatching for anything left behindWorried about familyInherited risk, and relativesWanting a second opinionA decision you are unsure aboutDecide
Blueprint CareThe flagship decision report and a dedicated clinical teamSignalOne free question answered on WhatsApp within four hoursNavigationRecords you already have, turned into a clarity timelineDecipherInterpretation of sequencing already done elsewhereTest: solid tumour
All Signature testsEvery panel compared, side by sideSignature STb33 genes from a blood drawSignature STb O118 genes from blood, including fusionsSignature STb O+523 genes, with TMB, MSI and pharmacogenomicsSignature STt OComprehensive profiling from a tissue blockTest: blood cancer
Signature BML+Myeloid, 600+ genes, with MDS and MPN overlapSignature BLL+Lymphoid, 600+ genes, with Philadelphia-like detectionSignature CustomDesigned around one question when neither family fitsMonitor
SentinelSerial monitoring while treatment is runningSentinel SolidctDNA monitoring for solid tumoursClearMolecular residual disease surveillanceClear SolidTumour-informed surveillance for solid tumoursClear BloodResidual disease surveillance after blood cancer treatmentProtect
HeritageInherited risk, assessed properlyHeritage CoreA broad inherited-risk assessmentHeritage AdhocFocused testing for named relativesCancer DictionaryWhat is discussed in your specific cancerReference
Cancer DictionaryOne structured entry per cancer typeBiomarker LibraryOne page per marker, in plain languagePatient ResourcesGlossary, guides and how to use themWatch, read and ask
Video LibraryShort explainers, captioned and translatedJourneysFour composites showing how a decision gets madeCase studiesNine situations and the test that fits eachFAQThe questions we are asked mostPrecision Oncology, Navigated
A diagnosis narrows your world to one question: what now? We turn the full molecular picture of your cancer into a clear, ranked plan, and put a clinical team beside you to act on it.
Not a test result. A decision, and someone to walk it with you.
The problem
Genomic tests can read hundreds of genes. Most people get back a page of letters and numbers, and no answer to the questions that actually matter.
We do the hard part: turning data into a decision you can act on.

The service
We bring together three things that are usually scattered: comprehensive molecular testing, expert interpretation, and continuous human care.
OnKommon builds the technology, the engine and the report.
KPCIRC, our exclusive partner, signs every decision.
A licensed clinician is accountable. No machine decides.
Our technology informs. A clinician decides.
The ecosystem
Most people start with Blueprint Care and grow into the rest as their needs change.
Stage 01
Decide
Read the whole tumour and rank the best treatment plan.
Blueprint CareStage 02
Track
Watch whether treatment is working and catch resistance early.
SentinelStage 03
Catch
Detect microscopic disease left behind or coming back.
ClearStage 04
Protect
Test for inherited risk and protect your family.
HeritageAlways connected. Navigation, clinical review, reporting and human guidance continue as needs change.
Phase 01
Begin with the molecular picture and turn scattered information into a ranked, clinically accountable plan. The goal is not another variant list. It is a clear decision the treating team can act on.
Select a stage to move through the journey. Each product bar shows when it is active.
Three stages
Every report follows the same path. Each stage is traceable, and a licensed human owns the last word.
From a blood draw or a tissue block, with quality control and per-gene coverage reported openly.
It annotates every alteration, matches drugs and trials, and applies six intelligence layers.
A molecular tumour board of licensed clinicians adds judgement and takes responsibility.
What is different
We rank the options, name what to avoid, and explain why.
Licensed clinicians author every consequential call.
Biosimilars, assistance programmes and government schemes, in your language.
The same team follows you from first decision to long-term monitoring.
We say what each test cannot do, and who signed your report.
Where inherited risk shows up, relatives get a tested pathway and counselling.

Our origin
OnKommon began inside the Kwatra Precision Cancer Institute and Research Centre, and stays in exclusive clinical partnership with it.
That is why our reports arrive with genuine clinical accountability rather than software output. It is the difference between a result and a plan.
Start where you are
Take the next step
A no-obligation conversation with our care team, arranged through KPCIRC.
Book a consultationCommission your decision report and a dedicated clinical team.
Explore Blueprint CareSignal replies to your first question within four hours, at no cost.
Start with Signal